Role of human papillomaviruses in carcinogenesis

ecancermedicalscience

Volumn 9, Issue , 2015, Pages

  Ghittoni, Raffaella ^a   Accardi, Rosita ^b   Chiocca, Susanna ^c   Tommasino, Massimo ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

Author keywords

Carcinogenesis; HPV vaccines; Papillomavirus

Indexed keywords

CAPSID PROTEIN L1; WART VIRUS VACCINE;

ANUS CANCER; CANCER SCREENING; CONDYLOMA ACUMINATUM; CYTOLOGY; DISEASE ASSOCIATION; EPIDERMODYSPLASIA VERRUCIFORMIS; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; MOLECULAR PATHOLOGY; NON MELANOMA SKIN CANCER; NONHUMAN; NUCLEOTIDE SEQUENCE; OROPHARYNX CANCER; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; PENIS CANCER; PHYLOGENETIC TREE; POLYMERASE CHAIN REACTION; REVIEW; SKIN PAPILLOMA; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DISEASE; VAGINA CANCER; VERRUCA VULGARIS; VIRUS CARCINOGENESIS; VIRUS ONCOGENE; VULVA CANCER; WART VIRUS;

EID: 84935001587     PISSN: None     EISSN: 17546605     Source Type: Journal    
DOI: 10.3332/ecancer.2015.526     Document Type: Review

References (65)

1. De Villiers EM et al (2004) Classification of papillomaviruses Virology 324(1) 17-27 DOI: 10.1016/j.virol.2004.03.033 PMID: 15183049
2. Bernard HU, Calleja-Macias IE and Dunn ST (2006) Genome variation of human papillomavirus types: phylogenetic and medical implications Int J Cancer 118(5) 1071-6 DOI: 10.1002/ijc.21655
3. Ghittoni R et al (2010) The biological properties of E6 and E7 oncoproteins from human papillomaviruses Virus Genes 40(1) 1-13 DOI: 10.1007/s11262-009-0412-8
4. Accardi R and Gheit (2014) Cutaneous HPV and skin cancer Press Med 43(12P2) e435-e443 DOI: 10.1016/j.lpm.2014.08.008
5. Haedicke J and Iftner T (2013) Human papillomaviruses and cancer Radiother Oncol 108(3) 397-402 DOI: 10.1016/j.radonc.2013.06.004 PMID: 23830197
6. Smola S (2014) Human papillomaviruses and skin cancer Adv Exp Med Biol 810 192-207 PMID: 25207367
7. Zur Hausen H (2002) Papillomaviruses and cancer: from basic studies to clinical application Nat Rev Cancer 2(5) 342-50 DOI: 10.1038/nrc798 PMID: 12044010
8. Bosch FX et al (1995) Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group [see comments] J Natl Cancer Inst 87(11) 796-802 DOI: 10.1093/jnci/87.11.796 PMID: 7791229
9. Munoz N et al (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer N Engl J Med 348(6) 518-27 DOI: 10.1056/NEJMoa021641 PMID: 12571259
10. Schiffman MH et al (1987) Biochemical epidemiology of cervical neoplasia: measuring cigarette smoke constituents in the cervix Cancer Res 47(14) 3886-8 PMID: 3594446
11. De Sanjose S et al (2010) Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study Lancet Oncol 11(11) 1048-56 DOI: 10.1016/S1470-2045(10)70230-8 PMID: 20952254
12. Smith JS et al (2007) Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update Int J Cancer 121(3) 621-32 DOI: 10.1002/ijc.22527 PMID: 17405118
13. Tommasino M (2014) The human papillomavirus family and its role in carcinogenesis Semin Cancer Biol 26 13-21 DOI: 10.1016/j.semcancer.2013.11.002
14. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans Human papillomaviruses (2007) IARC Monogr Eval Carcinog Risks Hum 90 1-636
15. Kreimer AR et al (2005) Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review Cancer Epidemiol Biomarkers Prev 14(2) 467-75 DOI: 10.1158/1055-9965.EPI-04-0551 PMID: 15734974
16. Anantharaman D et al (2013) Human papillomavirus infections and upper aero-digestive tract cancers: the ARCAGE study J Natl Cancer Inst 105(8) 536-45 DOI: 10.1093/jnci/djt053 PMID: 23503618
17. Herrero R et al (2003) Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study J Natl Cancer Inst 95(23) 1772-83 DOI: 10.1093/jnci/djg107 PMID: 14652239
18. Jablonska S, Dabrowski J and Jakubowicz K (1972) Epidermodysplasia verruciformis as a model in studies on the role of papovaviruses in oncogenesis Cancer Res 32(3) 583-99 PMID: 5061309
19. Lutzner MA (1978) Epidermodysplasia verruciformis. An autosomal recessive disease characterized by viral warts and skin cancer. A model for viral oncogenesis Bull Cancer 65(2) 169-82 PMID: 212144
20. Euvrard S et al (2001) Human papillomavirus and skin carcinoma in organ transplants. Recent studies Ann Dermatol Venereol 128(11) 1252-5
21. Pfister H (2003) Chapter 8: Human papillomavirus and skin cancer J Natl Cancer Inst Monogr (31) 52-6 DOI: 10.1093/oxfordjournals.jncimonographs.a003483 PMID: 12807946
22. De Koning MN et al (2009) Prevalence and associated factors of betapapillomavirus infections in individuals without cutaneous squamous cell carcinoma J Gen Virol 90 (Pt 7) 1611-21 DOI: 10.1099/vir.0.010017-0 PMID: 19321753
23. Ananthaswamy HN et al (1997) Sunlight and skin cancer: inhibition of p53 mutations in UV-irradiated mouse skin by sunscreens Nat Med 3(5) 510-4 DOI: 10.1038/nm0597-510 PMID: 9142118
24. Armstrong DJ and Roman A (1992) Mutagenesis of human papillomavirus types 6 and 16 E7 open reading frames alters the electrophoretic mobility of the expressed proteins J Gen Virol 73(Pt 5) 1275-9 DOI: 10.1099/0022-1317-73-5-1275 PMID: 1316945
25. Preston DS and Stern RS (1992) Nonmelanoma cancers of the skin N Engl J Med 327(23) 1649-62 DOI: 10.1056/NEJM199212033272307 PMID: 1435901
26. Parkin DM (2006) The global health burden of infection-associated cancers in the year 2002 Int J Cancer 118(12) 3030-44 DOI: 10.1002/ijc.21731 PMID: 16404738
27. Cuzick J et al (1999) HPV testing in primary screening of older women Br J Cancer 81(3) 554-8 DOI: 10.1038/sj.bjc.6690730 PMID: 10507785 PMCID: 2362918
28. Schneider A et al (1996) Screening for cervical intraepithelial neoplasia grade 2/3: validity of cytologic study, cervicography, and human papillomavirus detection Am J Obstet Gynecol 174(5) 1534-41 DOI: 10.1016/S0002-9378(96)70602-6 PMID: 9065125
29. Clavel C et al (2001) Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women Br J Cancer 84(12) 1616-23 DOI: 10.1054/bjoc.2001.1845 PMID: 11401314 PMCID: 2363679
30. Cuzick J et al (2006) Chapter 10: New dimensions in cervical cancer screening Vaccine 24(Suppl 3) S3/90-7 DOI: 10.1016/j.vaccine.2006.05.122
31. Dillner J, Rebolj M and Birembaut P et al (2008) Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study BMJ 337 1754 DOI: 10.1136/bmj.a1754
32. Sasieni P and Cuzick J (2002) Could HPV testing become the sole primary cervical screening test? J Med Screen 9(2) 49-51 DOI: 10.1136/jms.9.2.49 PMID: 12133918
33. Grce M and Davies P (2008) Human papillomavirus testing for primary cervical cancer screening Expert Rev Mol Diagn 8(5) 599-605 DOI: 10.1586/14737159.8.5.599 PMID: 18785808
34. Sankaranarayanan R et al (2009) HPV screening for cervical cancer in rural India N Engl J Med 360(14) 1385-94 DOI: 10.1056/NEJMoa0808516 PMID: 19339719
35. Sherman ME et al (2003) Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis J Natl Cancer Inst 95(1) 46-52 DOI: 10.1093/jnci/95.1.46 PMID: 12509400
36. Hoyer H et al (2005) Cumulative 5-year diagnoses of CIN2, CIN3 or cervical cancer after concurrent high-risk HPV and cytology testing in a primary screening setting Int J Cancer 116(1) 136-43 DOI: 10.1002/ijc.20955 PMID: 15756677
37. Lorincz AT (1996) Hybrid Capture method for detection of human papillomavirus DNA in clinical specimens: a tool for clinical management of equivocal Pap smears and for population screening J Obstet Gynaecol Res 22(6) 629-36 DOI: 10.1111/j.1447-0756.1996.tb01081.x PMID: 9037955
38. Ronco G et al (2006) Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial Lancet Oncol 7(7) 547-55 DOI: 10.1016/S1470-2045(06)70731-8 PMID: 16814206
39. Cuzick J et al (2006) Overview of the European and North American studies on HPV testing in primary cervical cancer screening Int J Cancer 119(5) 1095-101 DOI: 10.1002/ijc.21955 PMID: 16586444
40. Briolat J et al (2007) HPV prevalence, viral load and physical state of HPV-16 in cervical smears of patients with different grades of CIN Int J Cancer 121(10) 2198-204 DOI: 10.1002/ijc.22959 PMID: 17657742
41. Hesselink AT et al (2009) High-risk human papillomavirus DNA load in a population-based cervical screening cohort in relation to the detection of high-grade cervical intraepithelial neoplasia and cervical cancer Int J Cancer 124(2) 381-6 DOI: 10.1002/ijc.23940
42. Schmitt M et al (2010) Diagnosing cervical cancer and high-grade precursors by HPV16 transcription patterns Cancer Res 70(1) 249-56 DOI: 10.1158/0008-5472.CAN-09-2514
43. Cuschieri K and Wentzensen N. (2008) Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia Cancer Epidemiol Biomarkers Prev 17(10) 2536-45 DOI: 10.1158/1055-9965.EPI-08-0306 PMID: 18842994 PMCID: 2900792
44. Denton KJ et al (2010) The sensitivity and specificity of p16(INK4a) cytology vs HPV testing for detecting high-grade cervical disease in the triage of ASC-US and LSIL pap cytology results Am J Clin Pathol 134(1) 12-21 DOI: 10.1309/AJCP3CD9YKY-FJDQL PMID: 20551261
45. Ojesina AI et al (2014) Landscape of genomic alterations in cervical carcinomas Nature 506(7488) 371-5 DOI: 10.1038/nature12881 PMID: 24390348 PMCID: 4161954
46. Baker TS et al (1991) Structures of bovine and human papillomaviruses. Analysis by cryoelectron microscopy and three-dimensional image reconstruction Biophys J 60(6) 1445-56 DOI: 10.1016/S0006-3495(91)82181-6 PMID: 1663794 PMCID: 1260204
47. Ostör AG (1993) Natural history of cervical intraepithelial neoplasia: a critical review Int J Gynecol Pathol 12(2) 186-92 DOI: 10.1097/00004347-199304000-00018 PMID: 8463044
48. Pett M and Coleman N (2007) Integration of high-risk human papillomavirus: a key event in cervical carcinogenesis? J Pathol 212(4) 356-67 DOI: 10.1002/path.2192 PMID: 17573670
49. Gray E et al (2010) In vitro progression of human papillomavirus 16 episome-associated cervical neoplasia displays fundamental similarities to integrant-associated carcinogenesis Cancer Res 70(10) 4081-91 DOI: 10.1158/0008-5472.CAN-09-3335 PMID: 20442284 PMCID: 2872760
50. Moreno V et al (1995) Risk factors for progression of cervical intraepithelial neoplasm grade III to invasive cervical cancer Cancer Epidemiol Biomarkers Prev 4(5) 459-67 PMID: 7549800
51. Moreno V et al (2002) Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study Lancet 359(9312) 1085-92 DOI: 10.1016/S0140-6736(02)08150-3 PMID: 11943255
52. Munoz N et al (2002) Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study Lancet 359(9312) 1093-101 DOI: 10.1016/S0140-6736(02)08151-5 PMID: 11943256
53. Plummer M, Peto J and Franceschi S (2012) Time since first sexual intercourse and the risk of cervical cancer Int J Cancer 130(11) 2638-44 DOI: 10.1002/ijc.26250
54. Einstein MH et al (2009) Clinician's guide to human papillomavirus immunology: knowns and unknowns Lancet Infect Dis 9(6) 347-56 DOI: 10.1016/S1473-3099(09)70108-2 PMID: 19467474
55. Rodriguez AC et al (2008) Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections J Natl Cancer Inst 100(7) 513-7 DOI: 10.1093/jnci/djn044 PMID: 18364507 PMCID: 3705579
56. O'Brien PM and Campo MS (2003) Papillomaviruses: a correlation between immune evasion and oncogenicity? Trends Microbiol 11(7) 300-5 DOI: 10.1016/S0966-842X(03)00145-8
57. White EA et al (2012) Systematic identification of interactions between host cell proteins and E7 oncoproteins from diverse human papillomaviruses Proc Natl Acad Sci USA 109(5) E260-E267 DOI: 10.1073/pnas.1116776109 PMID: 22232672 PMCID: 3277141
58. White EA et al (2012) Comprehensive analysis of host cellular interactions with human papillomavirus E6 proteins identifies new E6 binding partners and reflects viral diversity J Virol 86(24) 13174-86 DOI: 10.1128/JVI.02172-12 PMID: 23015706 PMCID: 3503137
59. Howie HL, Katzenellenbogen RA and Galloway DA (2009) Papillomavirus E6 proteins Virology 384(2) 324-34 DOI: 10.1016/j.virol.2008.11.017 PMCID: 2674106
60. Joura EA, Giuliano AR and Iversen OE et al (2015) A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women N Engl J Med 372 711-23
61. Romanowski B et al (2009) Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years Lancet 374(9706) 1975-85 DOI: 10.1016/S0140-6736(09)61567-1 PMID: 19962185
62. Villa LL et al (2006) High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up Br J Cancer 95(11) 1459-66 DOI: 10.1038/sj.bjc.6603469 PMID: 17117182 PMCID: 2360730
63. Albers AE and Kaufmann AM (2009) Therapeutic human papillomavirus vaccination Public Health Genomics 12(5-6) 331-42 DOI: 10.1159/000214923 PMID: 19684445
64. Kanodia S, Da Silva DM and Kast WM (2008) Recent advances in strategies for immunotherapy of human papillomavirus-induced lesions Int J Cancer 122(2) 247-59 DOI: 10.1002/ijc.23252
65. Kenter GG et al (2009) Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia N Engl J Med 361(19) 1838-47 DOI: 10.1056/NEJMoa0810097 PMID: 19890126